Ardelyx (ARDX) Other Operating Expenses (2014 - 2026)
Ardelyx's (ARDX) quarterly Other Operating Expenses came in at $4.8 million in Q1 2026, down 60.9% YoY from $12.3 million in Q1 2025, and down 87.83% on a QoQ basis from $39.5 million in Q4 2025.
Ardelyx (ARDX) Other Operating Expenses (2014 - 2026) Analysis & Trends
Ardelyx (ARDX) has 11 years of Other Operating Expenses data on file, last reported at $4.8 million in Q1 2026.
- Quarterly Other Operating Expenses fell 60.9% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.3 million (down 29.45% YoY) and the FY2025 annual result came in at $39.5 million, down 21.8% from the prior year.
- Other Operating Expenses declined to $4.8 million in Q1 2026, from $39.5 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $50.6 million in Q4 2024 to a low of $85000.0 in Q1 2022.
- A 5-year average of $20.8 million and a median of $15.0 million in 2023 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses plunged 91.5% — and 2024, when it jumped 184.1%.
- Tracing ARDX's Other Operating Expenses over 5 years: stood at $85000.0 in 2022, then jumped by 20835.29% to $17.8 million in 2023, then jumped by 184.1% to $50.6 million in 2024, then decreased by 21.8% to $39.5 million in 2025, then sank by 87.83% to $4.8 million in 2026.
- The last three Other Operating Expenses figures came in at $4.8 million (Q1 2026), $39.5 million (Q4 2025), and $12.3 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ardelyx | 1.01 Bn | 729.71 Mn | 115.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.76 Mn |
| Mar 31, 2026 | 4.81 Mn |
| Dec 31, 2025 | 39.54 Mn |
| Mar 31, 2025 | 12.30 Mn |
| Dec 31, 2024 | 50.56 Mn |
| Dec 31, 2023 | 17.80 Mn |
| Mar 31, 2022 | 85,000.00 |
| Dec 31, 2021 | -1.00 Mn |
| Mar 31, 2021 | 1.00 Mn |
| Dec 31, 2020 | 4,000.00 |
| Jun 30, 2020 | 141,000.00 |
| Sep 30, 2019 | 600,000.00 |
| Mar 31, 2019 | 19.88 Mn |
| Dec 31, 2018 | 20.64 Mn |
| Jun 30, 2018 | 15.15 Mn |
| Mar 31, 2018 | 13.15 Mn |
| Dec 31, 2016 | 1,000.00 |
| Dec 31, 2014 | -2,000.00 |